Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Starling Oncology, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 14 | 13 | −1 |
| Shares | 3.32M | 3.36M | +36.1K (+1.1%) |
| Value | $3.90M | $1.61M | −$2.28M (−58.6%) |
New holders (0)
Institutions that held Starling Oncology, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
None.
Sold out (1)
Institutions that held Starling Oncology, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Man Group plc | 94,740 | $109.0K |